CHESTER L CRUMP

Allopathic & Osteopathic Physicians|Family Medicine HOPKINSVILLE, KY NPI 1477528339

General Payments — all program years on this page

$2,639.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 162
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $352.95 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $352.9521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $381.4627
2019 $191.0013
2020 $405.5725
2021 $543.2930
2022 $460.1630
2023 $304.8816
2024 $352.9521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086201780 Bayer Healthcare Pharmaceuticals Inc. $19.22 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086203523 Bayer Healthcare Pharmaceuticals Inc. $20.45 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103518858 ABBVIE INC. $14.99 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104347488 AstraZeneca Pharmaceuticals LP $14.36 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104394289 AstraZeneca Pharmaceuticals LP $17.75 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104597506 AstraZeneca Pharmaceuticals LP $16.10 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104732171 AstraZeneca Pharmaceuticals LP $2.19 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104741691 AstraZeneca Pharmaceuticals LP $19.56 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105229750 AstraZeneca Pharmaceuticals LP $13.27 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105490321 AstraZeneca Pharmaceuticals LP $15.02 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105550830 AstraZeneca Pharmaceuticals LP $18.15 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105701080 AstraZeneca Pharmaceuticals LP $14.72 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114624562 Exact Sciences Corporation $21.90 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117231401 Amgen Inc. $14.53 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117231403 Amgen Inc. $19.26 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117231405 Amgen Inc. $19.86 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117231407 Amgen Inc. $16.92 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125083591 Abbott Laboratories $18.63 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136093833 Lilly USA, LLC $19.39 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136098794 Lilly USA, LLC $15.95 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151052601 Phathom Pharmaceuticals, Inc. $20.73 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.